Progyny Inc

PGNY

Equity

ISIN null / Valor 50342281

NASDAQ (2025-11-21)

USD 25.86+4.15%

Progyny Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Progyny Inc. is a company that provides fertility and family building benefits solutions to employers, offering services that include access to a network of fertility specialists, treatment financing, and personalized support.

Summarized from source with an LLMView SourceSector: Healthcare

Record Revenue Growth

Revenue for the second quarter of 2025 reached $332.9 million, a 9.5% increase from $304.1 million in the second quarter of 2024. Excluding revenue from a major client transition, revenue grew by 18%, highlighting strong performance in both fertility and pharmacy benefit services.

Operating Cash Flow

Progyny generated $55.5 million in operating cash flow for the quarter and a record $105.3 million over the first half of 2025. This achievement underscores the company's ability to convert Adjusted EBITDA into cash efficiently.

Raised Full Year Guidance

The company has raised its full-year 2025 revenue guidance to $1.235 billion to $1.270 billion, reflecting a growth of 5.8% to 8.8%. When excluding the revenue from the transitioning large client, the expected growth ranges from 15.1% to 18.5%, driven by continued client acquisitions and increased member engagement.

Summarized from source with an LLMView Source

Key figures

72.7%1Y

-24.0%3Y

-15.2%5Y

Performance

47.8%1Y

52.3%3Y

55.4%5Y

Volatility